Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study

Purpose: Tranexamic acid (TXA) is prescribed for short term management of haemorrhage. It is also administered prophylatically in surgeries where blood loss is anticipated. Tranexamic mouth washes are also used in oral surgical procedures for patients with coagulopathies. The purpose of this study...

Full description

Bibliographic Details
Main Authors: Abu Dakir, Balakrishnan Ramalingam, Vijay Ebenezer, Prakash Dhanavelu
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2014-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/4313/8680_CE(Ra)_F(P)_PF1(PAK)_PFA(P)_PF2(PAG)_PF2(PN).pdf
id doaj-ac9165d394c344339f13ed05ccb937ed
record_format Article
spelling doaj-ac9165d394c344339f13ed05ccb937ed2020-11-25T03:15:49ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2014-05-0185ZC06ZC0810.7860/JCDR/2014/8680.4313Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot StudyAbu Dakir0Balakrishnan Ramalingam1Vijay Ebenezer2Prakash Dhanavelu3Reader, Department of Oral and Maxillofacial Surgery, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai, India.Professor, Department of Oral and Maxillofacial Surgery, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai, India.Professor, Department of Oral and Maxillofacial Surgery, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai, India.Reader, Department of Oral and Maxillofacial Surgery, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai, India.Purpose: Tranexamic acid (TXA) is prescribed for short term management of haemorrhage. It is also administered prophylatically in surgeries where blood loss is anticipated. Tranexamic mouth washes are also used in oral surgical procedures for patients with coagulopathies. The purpose of this study was to assess the efficiency of the usage of tranexamic acid on reduction of haemorrhage in maxillo mandibular trauma cases. Materials and Methods: Twelve consecutive male patients, between the ages 20-40 years, with multiple fractures of the facial bones, were included in this study. Six patients were administered either IV tranexamic acid (10 mg/kg- Group 1) and another six placebo (IV normal saline- Group 2) just before induction of anaesthesia. All patients were operated by the same surgical team, using the same standard techniques and the same anaesthetist and the same drugs were used during the surgery. Hypotension was induced for further reduction of intra operative blood loss. Intra and post-operative blood loss, operation time, transfusion of blood products, pre- and post-operative haemoglobin, number of days of hospitalisation and blood count were recorded for both groups. Results: Tranexamic acid significantly reduced the volume of blood loss during the surgery when compared with the control group (489.17± 106.7 mL vs 900.83 ± 113.7 mL). Considering the duration of operation and the treatment groups only, the mean total blood loss in the control group was 411.67 mL more than that in the tranexamic acid group. None of the patients of the TXA group required blood transfusion post-operatively. There was no difference in the length of hospital stay between the 2 groups. Two of the patients of the saline group required blood transfusion post-surgery due to significant drop in haemoglobin. The average drop in haemoglobin was 2 ± 1.4 in the tranexamic group and 4 ± 1.09 in the saline group. Conclusion: Pre-operative intravenous bolus administration of tranexamic acid at 10 mg/kg reduces blood loss compared with placebo during the surgery.https://jcdr.net/articles/PDF/4313/8680_CE(Ra)_F(P)_PF1(PAK)_PFA(P)_PF2(PAG)_PF2(PN).pdftranexamic acid (txa)normal saline (ns)haemorrhagesurgery
collection DOAJ
language English
format Article
sources DOAJ
author Abu Dakir
Balakrishnan Ramalingam
Vijay Ebenezer
Prakash Dhanavelu
spellingShingle Abu Dakir
Balakrishnan Ramalingam
Vijay Ebenezer
Prakash Dhanavelu
Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
Journal of Clinical and Diagnostic Research
tranexamic acid (txa)
normal saline (ns)
haemorrhage
surgery
author_facet Abu Dakir
Balakrishnan Ramalingam
Vijay Ebenezer
Prakash Dhanavelu
author_sort Abu Dakir
title Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
title_short Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
title_full Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
title_fullStr Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
title_full_unstemmed Efficacy of Tranexamic Acid in Reducing Blood Loss during Maxillofacial Trauma Surgery–A Pilot Study
title_sort efficacy of tranexamic acid in reducing blood loss during maxillofacial trauma surgery–a pilot study
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2014-05-01
description Purpose: Tranexamic acid (TXA) is prescribed for short term management of haemorrhage. It is also administered prophylatically in surgeries where blood loss is anticipated. Tranexamic mouth washes are also used in oral surgical procedures for patients with coagulopathies. The purpose of this study was to assess the efficiency of the usage of tranexamic acid on reduction of haemorrhage in maxillo mandibular trauma cases. Materials and Methods: Twelve consecutive male patients, between the ages 20-40 years, with multiple fractures of the facial bones, were included in this study. Six patients were administered either IV tranexamic acid (10 mg/kg- Group 1) and another six placebo (IV normal saline- Group 2) just before induction of anaesthesia. All patients were operated by the same surgical team, using the same standard techniques and the same anaesthetist and the same drugs were used during the surgery. Hypotension was induced for further reduction of intra operative blood loss. Intra and post-operative blood loss, operation time, transfusion of blood products, pre- and post-operative haemoglobin, number of days of hospitalisation and blood count were recorded for both groups. Results: Tranexamic acid significantly reduced the volume of blood loss during the surgery when compared with the control group (489.17± 106.7 mL vs 900.83 ± 113.7 mL). Considering the duration of operation and the treatment groups only, the mean total blood loss in the control group was 411.67 mL more than that in the tranexamic acid group. None of the patients of the TXA group required blood transfusion post-operatively. There was no difference in the length of hospital stay between the 2 groups. Two of the patients of the saline group required blood transfusion post-surgery due to significant drop in haemoglobin. The average drop in haemoglobin was 2 ± 1.4 in the tranexamic group and 4 ± 1.09 in the saline group. Conclusion: Pre-operative intravenous bolus administration of tranexamic acid at 10 mg/kg reduces blood loss compared with placebo during the surgery.
topic tranexamic acid (txa)
normal saline (ns)
haemorrhage
surgery
url https://jcdr.net/articles/PDF/4313/8680_CE(Ra)_F(P)_PF1(PAK)_PFA(P)_PF2(PAG)_PF2(PN).pdf
work_keys_str_mv AT abudakir efficacyoftranexamicacidinreducingbloodlossduringmaxillofacialtraumasurgeryapilotstudy
AT balakrishnanramalingam efficacyoftranexamicacidinreducingbloodlossduringmaxillofacialtraumasurgeryapilotstudy
AT vijayebenezer efficacyoftranexamicacidinreducingbloodlossduringmaxillofacialtraumasurgeryapilotstudy
AT prakashdhanavelu efficacyoftranexamicacidinreducingbloodlossduringmaxillofacialtraumasurgeryapilotstudy
_version_ 1724637374863900672